Trademark Overview
On Monday, May 12, 2025, a trademark application was filed for CGT 360 with the United States Patent and Trademark Office. The USPTO has given the CGT 360 trademark a serial number of 99180190. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, December 9, 2025. This trademark is owned by Emerging Therapy Solutions, Inc.. The CGT 360 trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Financial consultation to healthcare providers, namely, providing assistance in managing health care expenses related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Group financial risk management services, namely, health care expense risk pooling and financial risk management services related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing financial and insurance information and consulting in the fields of insurance and healthcare preferred provider networks relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; preferred provider network programs, namely, administration of medical services in the nature of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies provided through a network of health care providers; Preferred provider network services, namel...
Business management and consulting services for the health care industry, namely, business management of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies for health plans, health insurers, self-funded plans, and reinsurers; Business management and administration in the field of healthcare, namely, development, creation and implementation of health care provider networks in the field of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Business administration of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapy programs; Business data analytics services, namely, health data collection and analysis in the nature of data compiling and analyzing to provide information and metrics regarding health insurance claims to help clients forecast outcomes, business risk, and expenses; Data acquisition and collection for insurance services for bu...
Consulting services in the field of medical care, namely, developing medical treatment policies related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing medical information in the field of cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Concierge medical services, namely, personal health care concierge services to guide patients through medical treatments related to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Medical consultations, namely, consulting, advising, and assisting patients and families with navigating the complex healthcare system relating to cell and gene therapies, solid organ and bone marrow transplants, and other complex medical therapies; Providing information in the field of health care, namely, models of care, medical practice, and health care delivery and outcomes, all relating to cell and...
